1. Document
     Procedure Note (V3) (2.16.840.1.113883.10.20.22.1.6)
    1. datatypelevel
       US Realm Date and Time (DT.US.FIELDED) (2.16.840.1.113883.10.20.22.5.3)
    2. Section
       Complications Section (V3) (2.16.840.1.113883.10.20.22.2.37)
      1. Entry
         Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Age Observation (2.16.840.1.113883.10.20.22.4.31)
        3. Entry
           Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
        4. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        5. Entry
           Problem Status (2.16.840.1.113883.10.20.22.4.6)
    3. Section
       Procedure Description Section (2.16.840.1.113883.10.20.22.2.27)
    4. Section
       Procedure Indications Section (V2) (2.16.840.1.113883.10.20.22.2.29)
      1. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
    5. Section
       Postprocedure Diagnosis Section (V3) (2.16.840.1.113883.10.20.22.2.36)
      1. Entry
         Postprocedure Diagnosis (V3) (2.16.840.1.113883.10.20.22.4.51)
        1. Entry
           Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Age Observation (2.16.840.1.113883.10.20.22.4.31)
          3. Entry
             Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
          4. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          5. Entry
             Problem Status (2.16.840.1.113883.10.20.22.4.6)
    6. Section
       Assessment Section (2.16.840.1.113883.10.20.22.2.8)
    7. Section
       Assessment and Plan Section (V2) (2.16.840.1.113883.10.20.22.2.9)
      1. Entry
         Planned Act (V2) (2.16.840.1.113883.10.20.22.4.39)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
    8. Section
       Plan of Treatment Section (V2) (2.16.840.1.113883.10.20.22.2.10)
      1. Entry
         Planned Observation (V2) (2.16.840.1.113883.10.20.22.4.44)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Planned Encounter (V2) (2.16.840.1.113883.10.20.22.4.40)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        3. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      3. Entry
         Planned Act (V2) (2.16.840.1.113883.10.20.22.4.39)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      4. Entry
         Planned Procedure (V2) (2.16.840.1.113883.10.20.22.4.41)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
      5. Entry
         Planned Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.42)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
      6. Entry
         Planned Supply (V2) (2.16.840.1.113883.10.20.22.4.43)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        3. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        5. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        6. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        7. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
      7. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      8. Entry
         Handoff Communication Participants (2.16.840.1.113883.10.20.22.4.141)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      9. Entry
         Nutrition Recommendation (2.16.840.1.113883.10.20.22.4.130)
        1. Entry
           Planned Encounter (V2) (2.16.840.1.113883.10.20.22.4.40)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          3. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        2. Entry
           Planned Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.42)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        3. Entry
           Planned Observation (V2) (2.16.840.1.113883.10.20.22.4.44)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Planned Procedure (V2) (2.16.840.1.113883.10.20.22.4.41)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        5. Entry
           Planned Supply (V2) (2.16.840.1.113883.10.20.22.4.43)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          5. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          6. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          7. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        6. Entry
           Planned Act (V2) (2.16.840.1.113883.10.20.22.4.39)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      10. Entry
         Planned Immunization Activity (2.16.840.1.113883.10.20.22.4.120)
        1. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
      11. Entry
         Goal Observation (2.16.840.1.113883.10.20.22.4.121)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Entry Reference (2.16.840.1.113883.10.20.22.4.122)
        3. Entry
           Entry Reference (2.16.840.1.113883.10.20.22.4.122)
        4. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        5. @
           Goal Observation (2.16.840.1.113883.10.20.22.4.121)
        6. Entry
           Entry Reference (2.16.840.1.113883.10.20.22.4.122)
        7. Entry
           External Document Reference (2.16.840.1.113883.10.20.22.4.115)
    9. Section
       Allergies and Intolerances Section (entries optional) (V3) (2.16.840.1.113883.10.20.22.2.6)
      1. Entry
         Allergy Concern Act (V3) (2.16.840.1.113883.10.20.22.4.30)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Allergy - Intolerance Observation (V2) (2.16.840.1.113883.10.20.22.4.7)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. Entry
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. notype
                   Author Participation (2.16.840.1.113883.10.20.22.4.119)
                3. Entry
                   Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
                4. Entry
                   Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
                5. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                6. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                7. Entry
                   Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. datatypelevel
                     US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                  4. Entry
                     Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                    1. Entry
                       Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                    2. Entry
                       Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                    3. Entry
                       Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                8. @
                   Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
                9. Entry
                   Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                  1. datatypelevel
                     US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
                10. Entry
                   Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
                11. Entry
                   Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
                12. Entry
                   Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. Entry
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              3. Entry
                 Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              5. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              6. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              7. Entry
                 Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. datatypelevel
                   US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                4. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              8. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              9. Entry
                 Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                1. datatypelevel
                   US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
              10. Entry
                 Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
              11. Entry
                 Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
              12. Entry
                 Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          4. Entry
             Criticality Observation (2.16.840.1.113883.10.20.22.4.145)
    10. Section
       Anesthesia Section (V2) (2.16.840.1.113883.10.20.22.2.25)
      1. Entry
         Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        3. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        6. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. @
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        7. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. @
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          2. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      2. Entry
         Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          4. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. @
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
          1. datatypelevel
             US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
        11. Entry
           Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
        12. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    11. Section
       Chief Complaint Section (1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1)
    12. Section
       Chief Complaint and Reason for Visit Section (2.16.840.1.113883.10.20.22.2.13)
    13. Section
       Family History Section (V3) (2.16.840.1.113883.10.20.22.2.15)
      1. Entry
         Family History Organizer (V3) (2.16.840.1.113883.10.20.22.4.45)
        1. Entry
           Family History Observation (V3) (2.16.840.1.113883.10.20.22.4.46)
          1. Entry
             Age Observation (2.16.840.1.113883.10.20.22.4.31)
          2. Entry
             Family History Death Observation (2.16.840.1.113883.10.20.22.4.47)
    14. Section
       Past Medical History (V3) (2.16.840.1.113883.10.20.22.2.20)
      1. Entry
         Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Age Observation (2.16.840.1.113883.10.20.22.4.31)
        3. Entry
           Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
        4. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        5. Entry
           Problem Status (2.16.840.1.113883.10.20.22.4.6)
    15. Section
       History of Present Illness Section (1.3.6.1.4.1.19376.1.5.3.1.3.4)
    16. Section
       Medical (General) History Section (2.16.840.1.113883.10.20.22.2.39)
    17. Section
       Medications Section (entries optional) (V2) (2.16.840.1.113883.10.20.22.2.1)
      1. Entry
         Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          4. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. @
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
          1. datatypelevel
             US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
        11. Entry
           Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
        12. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    18. Section
       Medications Administered Section (V2) (2.16.840.1.113883.10.20.22.2.38)
      1. Entry
         Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          4. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. @
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
          1. datatypelevel
             US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
        11. Entry
           Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
        12. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    19. Section
       Physical Exam Section (V3) (2.16.840.1.113883.10.20.2.10)
      1. Entry
         Longitudinal Care Wound Observation (V2) (2.16.840.1.113883.10.20.22.4.114)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Wound Measurement Observation (2.16.840.1.113883.10.20.22.4.133)
        3. Entry
           Wound Characteristic (2.16.840.1.113883.10.20.22.4.134)
        4. Entry
           Number of Pressure Ulcers Observation (V3) (2.16.840.1.113883.10.20.22.4.76)
        5. Entry
           Highest Pressure Ulcer Stage (2.16.840.1.113883.10.20.22.4.77)
    20. Section
       Planned Procedure Section (V2) (2.16.840.1.113883.10.20.22.2.30)
      1. Entry
         Planned Procedure (V2) (2.16.840.1.113883.10.20.22.4.41)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
    21. Section
       Procedure Disposition Section (2.16.840.1.113883.10.20.18.2.12)
    22. Section
       Procedure Estimated Blood Loss Section (2.16.840.1.113883.10.20.18.2.9)
    23. Section
       Procedure Findings Section (V3) (2.16.840.1.113883.10.20.22.2.28)
      1. Entry
         Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Age Observation (2.16.840.1.113883.10.20.22.4.31)
        3. Entry
           Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
        4. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        5. Entry
           Problem Status (2.16.840.1.113883.10.20.22.4.6)
    24. Section
       Procedure Implants Section (2.16.840.1.113883.10.20.22.2.40)
    25. Section
       Procedure Specimens Taken Section (2.16.840.1.113883.10.20.22.2.31)
    26. Section
       Procedures Section (entries optional) (V2) (2.16.840.1.113883.10.20.22.2.7)
      1. Entry
         Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        3. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        6. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. @
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        7. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. @
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          2. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      2. Entry
         Procedure Activity Observation (V2) (2.16.840.1.113883.10.20.22.4.13)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        6. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. Entry
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              3. Entry
                 Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              5. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              6. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              7. Entry
                 Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. datatypelevel
                   US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                4. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              8. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              9. Entry
                 Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                1. datatypelevel
                   US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
              10. Entry
                 Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
              11. Entry
                 Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
              12. Entry
                 Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      3. Entry
         Procedure Activity Act (V2) (2.16.840.1.113883.10.20.22.4.12)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    27. Section
       Reason for Visit Section (2.16.840.1.113883.10.20.22.2.12)
    28. Section
       Review of Systems Section (1.3.6.1.4.1.19376.1.5.3.1.3.18)
    29. Section
       Social History Section (V3) (2.16.840.1.113883.10.20.22.2.17)
      1. Entry
         Social History Observation (V3) (2.16.840.1.113883.10.20.22.4.38)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Pregnancy Observation (2.16.840.1.113883.10.20.15.3.8)
        1. Entry
           Estimated Date of Delivery (2.16.840.1.113883.10.20.15.3.1)
      3. Entry
         Smoking Status - Meaningful Use (V2) (2.16.840.1.113883.10.20.22.4.78)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      4. Entry
         Tobacco Use (V2) (2.16.840.1.113883.10.20.22.4.85)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      5. Entry
         Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
      6. Entry
         Cultural and Religious Observation (2.16.840.1.113883.10.20.22.4.111)
      7. Entry
         Characteristics of Home Environment (2.16.840.1.113883.10.20.22.4.109)